Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tesofensine and Metoprolol Interaction on Heart Rate
NCT03488719Phase 1Completed
- Sponsor
- Saniona
- Start
- Jul 2018
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tesofensine in obesity and Overweight (3 cohorts), sponsored by Saniona. Primary endpoint: Dose of Metoprolol Resulting in no Change in Mean Heart Rate Over 24 Hours at Day 23. Started Jul 2018; status: completed.
02
Drugs
tesofensine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT03488719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03488719.